Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for affective symptoms in first-episode psychosis (pilot)
2005-005839-10Phase 4Completed
- Sponsor
- Georg-August-Universität Göttingen
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of quetiapine in schizophrenia, sponsored by Georg-August-Universität Göttingen. Primary endpoint: Change in Hamilton Depression Rating Scale (HAMD). Started Aug 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2005-005839-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005839-10.